Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.892 SEK | -6.11% | -1.11% | +1.36% |
Feb. 27 | Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 21.03M 230M |
---|---|---|---|---|---|
Net income 2021 | -31M -339M | Net income 2022 | -13M -142M | EV / Sales 2021 | - |
Net cash position 2021 | 16.42M 180M | Net cash position 2022 | 13.58M 149M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.15
x | P/E ratio 2022 |
-1.31
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 57.98% |
1 day | -6.11% | ||
1 week | -1.11% | ||
Current month | -0.89% | ||
1 month | -7.08% | ||
3 months | -28.64% | ||
6 months | +20.54% | ||
Current year | +1.36% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Nordkild
CEO | Chief Executive Officer | 69 | 15-12-31 |
Director of Finance/CFO | 69 | 17-03-31 | |
Public Communications Contact | 62 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul de Potocki
CHM | Chairman | 62 | 17-12-31 |
Public Communications Contact | 62 | 10-12-31 | |
Marianne Kock
BRD | Director/Board Member | 69 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.892 | -6.11% | 3,318 |
24-04-25 | 0.95 | 0.00% | 22,785 |
24-04-24 | 0.95 | +1.50% | 1,768 |
24-04-23 | 0.936 | +4.00% | 22,999 |
24-04-22 | 0.9 | -0.22% | 11,253 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 10:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+1.36% | 1.84M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ASAP Stock